Evaluation of interleukin 6 (IL-6) and interleukin 8 (IL-8) as prognosis factors in Coronavirus disease (COVID-19)
Researcher Bulletin of Medical Sciences,
Vol. 28 No. 1 (2023),
9 January 2024,
Page e1
Background and Objective: Better understanding of immunopathogenesis and finding the relationship between disease severity and some cytokines, is an introduction to further research on new biological drugs with the specific aim of obtaining these cytokines can be provided. The present study was performed to determine the ratios of IL-6 and IL-8 (IL-6, IL-8) in Iranian patients with COVID-19.
Materials and Methods: One of our goals is to find a relationship between serums levels of hypothetical cytokines involved in the severity of COVID-19 disease by measuring the serum concentrations of these cytokines in COVID-19 patients at baseline as a prognostic factor.
Results: Regarding right lung involvement as well as involvement of both lungs, there was a significant difference between patients with severe and mild disease severity (p-value <0.001). Ferritin levels were significantly higher in the severely ill group than in the mildly ill group (p-value = 0.003). CRP levels were higher than normal in 93.3% of patients in the present study. CRP levels were not associated with disease severity but were effective in predicting the disease. ESR level was higher than normal in 88% of patients and was effective in prognosis the disease. The mean serum level of interleukin-8 in 38 severe patients was significantly higher than the mean serum level of interleukin 8 in 21 mild patients (p-value <0.001). Death was reported in 11 patients (18.6%). Mortality rate and disease severity showed a significant relationship (p-value = 0.006). The disease was significantly more severe in patients with positive PCR (p-value = 0.026).
Conclusions: In several patients, the serum level of interleukin 8 has been a good evaluator of disease prognosis. Symptoms of COVID-19 may be due to elevated levels of interleukin-8 and its receptor. Therefore, it is suggested that in future studies, interleukin 8 receptor mRNA be tested for the discovery of new biological drugs against COVID-19.